{"transactions":[{"id":2062657,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-01-05T20:01:41.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":102700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These stock options vest in a series of 48 equal monthly installments measured from January 3, 2023, subject to the reporting person's continued service."}],"balance_after":102700,"derivative":{"exercise_price":1.23,"expiration_date":"2033-01-02","underlying":"Common Stock","underlying_shares":102700},"source":{"system":"sec-edgar","filing":"0001209191-23-002146","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000120919123002146/doc4.xml","form_type":"4"}},{"id":2177192,"issuer":{"id":112530,"kind":"organization","name":"HTG MOLECULAR DIAGNOSTICS, INC","symbol":"HTGM"},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-08-22T17:27:24.000Z","date":"2022-08-18","kind":"grant","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the shares will vest twelve months after August 18, 2022 and the remaining shares will vest monthly in equal installments over a two year period such that the stock option is fully vested on the third anniversary of August 18, 2022."}],"balance_after":8000,"derivative":{"exercise_price":0.94,"expiration_date":"2032-08-17","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001209191-22-047052","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1169987/000120919122047052/doc4.xml","form_type":"4"}},{"id":2224101,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-22T16:31:29.000Z","date":"2022-06-21","kind":"grant","acquired":true,"shares":87801,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests over four (4) years, with one-fourth (1/4) of the award vesting on the first anniversary of the date of grant and the remainder of the award vesting in equal monthly installments thereafter, subject to the reporting person's continuous service through each vesting date."}],"balance_after":87801,"derivative":{"exercise_price":2.35,"expiration_date":"2032-06-20","underlying":"Common Stock","underlying_shares":87801},"source":{"system":"sec-edgar","filing":"0001179110-22-003399","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000117911022003399/edgar.xml","form_type":"4"}},{"id":2437742,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2022-01-11T18:36:17.000Z","date":"2022-01-07","kind":"purchase","acquired":true,"shares":2000,"price":4.78,"value":9560.0,"ownership":{"direct":true},"balance_after":113343,"source":{"system":"sec-edgar","filing":"0001209191-22-002963","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000120919122002963/doc4.xml","form_type":"4"}},{"id":2441561,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-06T19:22:32.000Z","date":"2022-01-04","kind":"grant","acquired":true,"shares":53100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These stock options vest in a series of 48 equal monthly installments measured from January 4, 2022, subject to the reporting person's continued service."}],"balance_after":53100,"derivative":{"exercise_price":5.45,"expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":53100},"source":{"system":"sec-edgar","filing":"0001209191-22-002245","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000120919122002245/doc4.xml","form_type":"4"}},{"id":2651738,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":true,"officer":true,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-29T21:55:26.000Z","date":"2021-06-25","kind":"grant","acquired":true,"shares":1000000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the merger of Millendo Therapeutics, Inc. (\"Millendo\") and private company Tempest Therapeutics, Inc. (\"Tempest\"), pursuant to the Agreement and Plan of Merger dated March 29, 2021 (the \"Merger Agreement\"), which closed on June 25, 2021 (\"Closing\"), (i) each share of Tempest's common stock converted into the right to receive approximately 0.0322 shares of Millendo common stock (the \"Exchange Ratio\"), and (ii) each outstanding and unexercised option to purchase shares of Tempest common stock converted into an option to purchase shares of Millendo's common stock, with necessary adjustments to reflect the Exchange Ratio but otherwise the same terms and conditions. The Exchange Ratio gives effect to the 15-to-1 reverse stock split of Millendo's common stock. On the Closing date, the closing price of Millendo common stock was $1.06 (unadjusted). Upon Closing, Millendo was renamed \"Tempest Therapeutics, Inc.\""},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These stock options vest in a series of 48 equal monthly installments measured from the vesting commencement date of Closing, June 25, 2021, subject to the reporting person's continued service."}],"balance_after":1000000,"derivative":{"exercise_price":26.4,"expiration_date":"2031-04-28","underlying":"Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001140361-21-022784","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000114036121022784/form4.xml","form_type":"4"}},{"id":2651737,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":true,"officer":true,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-29T21:55:26.000Z","date":"2021-06-25","kind":"grant","acquired":true,"shares":8050,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the merger of Millendo Therapeutics, Inc. (\"Millendo\") and private company Tempest Therapeutics, Inc. (\"Tempest\"), pursuant to the Agreement and Plan of Merger dated March 29, 2021 (the \"Merger Agreement\"), which closed on June 25, 2021 (\"Closing\"), (i) each share of Tempest's common stock converted into the right to receive approximately 0.0322 shares of Millendo common stock (the \"Exchange Ratio\"), and (ii) each outstanding and unexercised option to purchase shares of Tempest common stock converted into an option to purchase shares of Millendo's common stock, with necessary adjustments to reflect the Exchange Ratio but otherwise the same terms and conditions. The Exchange Ratio gives effect to the 15-to-1 reverse stock split of Millendo's common stock. On the Closing date, the closing price of Millendo common stock was $1.06 (unadjusted). Upon Closing, Millendo was renamed \"Tempest Therapeutics, Inc.\""},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These stock options vest in a series of 48 equal monthly installments measured from the vesting commencement date of March 5, 2021, subject to the reporting person's continued service. Notwithstanding the foregoing, if, within three months prior to or 12 months following a change in control, the Issuer terminates the reporting person's employment without cause or the reporting person resigns for good reasons, then the vesting of all of the shares subject to this option will be immediately accelerated such that all shares subject to the option will be deemed fully vested and exercisable as of the reporting person's last day of employment, provided that the reporting person satisfies certain severance conditions."}],"balance_after":8050,"derivative":{"exercise_price":10.25,"expiration_date":"2031-03-09","underlying":"Common Stock","underlying_shares":8050},"source":{"system":"sec-edgar","filing":"0001140361-21-022784","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000114036121022784/form4.xml","form_type":"4"}},{"id":2651736,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":true,"officer":true,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-29T21:55:26.000Z","date":"2021-06-25","kind":"grant","acquired":true,"shares":45988,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the merger of Millendo Therapeutics, Inc. (\"Millendo\") and private company Tempest Therapeutics, Inc. (\"Tempest\"), pursuant to the Agreement and Plan of Merger dated March 29, 2021 (the \"Merger Agreement\"), which closed on June 25, 2021 (\"Closing\"), (i) each share of Tempest's common stock converted into the right to receive approximately 0.0322 shares of Millendo common stock (the \"Exchange Ratio\"), and (ii) each outstanding and unexercised option to purchase shares of Tempest common stock converted into an option to purchase shares of Millendo's common stock, with necessary adjustments to reflect the Exchange Ratio but otherwise the same terms and conditions. The Exchange Ratio gives effect to the 15-to-1 reverse stock split of Millendo's common stock. On the Closing date, the closing price of Millendo common stock was $1.06 (unadjusted). Upon Closing, Millendo was renamed \"Tempest Therapeutics, Inc.\""},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These stock options vest in a series of 48 equal monthly installments measured from the vesting commencement date of February 20, 2020, subject to the reporting person's continued service. Notwithstanding the foregoing, if, within three months prior to or 12 months following a change in control, the Issuer terminates the reporting person's employment without cause or the reporting person resigns for good reasons, then the vesting of all of the shares subject to this option will be immediately accelerated such that all shares subject to the option will be deemed fully vested and exercisable as of the reporting person's last day of employment, provided that the reporting person satisfies certain severance conditions."}],"balance_after":45988,"derivative":{"exercise_price":5.9,"expiration_date":"2030-03-29","underlying":"Common Stock","underlying_shares":45988},"source":{"system":"sec-edgar","filing":"0001140361-21-022784","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000114036121022784/form4.xml","form_type":"4"}},{"id":2651735,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":true,"officer":true,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-29T21:55:26.000Z","date":"2021-06-25","kind":"grant","acquired":true,"shares":36263,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the merger of Millendo Therapeutics, Inc. (\"Millendo\") and private company Tempest Therapeutics, Inc. (\"Tempest\"), pursuant to the Agreement and Plan of Merger dated March 29, 2021 (the \"Merger Agreement\"), which closed on June 25, 2021 (\"Closing\"), (i) each share of Tempest's common stock converted into the right to receive approximately 0.0322 shares of Millendo common stock (the \"Exchange Ratio\"), and (ii) each outstanding and unexercised option to purchase shares of Tempest common stock converted into an option to purchase shares of Millendo's common stock, with necessary adjustments to reflect the Exchange Ratio but otherwise the same terms and conditions. The Exchange Ratio gives effect to the 15-to-1 reverse stock split of Millendo's common stock. On the Closing date, the closing price of Millendo common stock was $1.06 (unadjusted). Upon Closing, Millendo was renamed \"Tempest Therapeutics, Inc.\""},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All of the shares underlying this option vest upon Closing."}],"balance_after":36263,"derivative":{"exercise_price":4.97,"expiration_date":"2028-10-02","underlying":"Common Stock","underlying_shares":36263},"source":{"system":"sec-edgar","filing":"0001140361-21-022784","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000114036121022784/form4.xml","form_type":"4"}},{"id":2651734,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":true,"officer":true,"officer_title":"President"}}],"security":"Common Stock","published_at":"2021-06-29T21:55:26.000Z","date":"2021-06-25","kind":"grant","acquired":true,"shares":111343,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the merger of Millendo Therapeutics, Inc. (\"Millendo\") and private company Tempest Therapeutics, Inc. (\"Tempest\"), pursuant to the Agreement and Plan of Merger dated March 29, 2021 (the \"Merger Agreement\"), which closed on June 25, 2021 (\"Closing\"), (i) each share of Tempest's common stock converted into the right to receive approximately 0.0322 shares of Millendo common stock (the \"Exchange Ratio\"), and (ii) each outstanding and unexercised option to purchase shares of Tempest common stock converted into an option to purchase shares of Millendo's common stock, with necessary adjustments to reflect the Exchange Ratio but otherwise the same terms and conditions. The Exchange Ratio gives effect to the 15-to-1 reverse stock split of Millendo's common stock. On the Closing date, the closing price of Millendo common stock was $1.06 (unadjusted). Upon Closing, Millendo was renamed \"Tempest Therapeutics, Inc.\""}],"balance_after":111343,"source":{"system":"sec-edgar","filing":"0001140361-21-022784","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000114036121022784/form4.xml","form_type":"4"}},{"id":4236616,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-08-11T20:03:05.000Z","date":"2017-08-11","kind":"exercise","acquired":false,"shares":9088,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the Option vest in 48 equal monthly installments from the vesting commencement date of July 31, 2014."}],"balance_after":126328,"derivative":{"exercise_price":1,"expiration_date":"2024-07-30","underlying":"Common Stock","underlying_shares":9088},"source":{"system":"sec-edgar","filing":"0001209191-17-048673","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000120919117048673/doc4.xml","form_type":"4"}},{"id":4236615,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-08-11T20:03:05.000Z","date":"2017-08-10","kind":"exercise","acquired":false,"shares":40912,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the Option vest in 48 equal monthly installments from the vesting commencement date of July 31, 2014."}],"balance_after":135416,"derivative":{"exercise_price":1,"expiration_date":"2024-07-30","underlying":"Common Stock","underlying_shares":40912},"source":{"system":"sec-edgar","filing":"0001209191-17-048673","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000120919117048673/doc4.xml","form_type":"4"}},{"id":4236614,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-08-11T20:03:05.000Z","date":"2017-08-11","kind":"sale","acquired":false,"shares":9088,"price":11.1728,"value":101538.4064,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.10 to $11.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":39900,"source":{"system":"sec-edgar","filing":"0001209191-17-048673","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000120919117048673/doc4.xml","form_type":"4"}},{"id":4236613,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-08-11T20:03:05.000Z","date":"2017-08-11","kind":"exercise","acquired":true,"shares":9088,"price":1,"value":9088.0,"ownership":{"direct":true},"balance_after":48988,"source":{"system":"sec-edgar","filing":"0001209191-17-048673","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000120919117048673/doc4.xml","form_type":"4"}},{"id":4236612,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-08-11T20:03:05.000Z","date":"2017-08-10","kind":"sale","acquired":false,"shares":40912,"price":11.431,"value":467665.072,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.10 to $12.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":39900,"source":{"system":"sec-edgar","filing":"0001209191-17-048673","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000120919117048673/doc4.xml","form_type":"4"}},{"id":4236611,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-08-11T20:03:05.000Z","date":"2017-08-10","kind":"exercise","acquired":true,"shares":40912,"price":1,"value":40912.0,"ownership":{"direct":true},"balance_after":80812,"source":{"system":"sec-edgar","filing":"0001209191-17-048673","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000120919117048673/doc4.xml","form_type":"4"}},{"id":4261973,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-07-06T19:10:46.000Z","date":"2017-07-06","kind":"exercise","acquired":false,"shares":4512,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to the Option were fully vested as of September 1, 2015."}],"balance_after":13571,"derivative":{"exercise_price":0.52,"expiration_date":"2021-10-23","underlying":"Common Stock","underlying_shares":4512},"source":{"system":"sec-edgar","filing":"0001209191-17-044232","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000120919117044232/doc4.xml","form_type":"4"}},{"id":4261972,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-07-06T19:10:46.000Z","date":"2017-07-05","kind":"exercise","acquired":false,"shares":33688,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to the Option were fully vested as of September 1, 2015."}],"balance_after":18083,"derivative":{"exercise_price":0.52,"expiration_date":"2021-10-23","underlying":"Common Stock","underlying_shares":33688},"source":{"system":"sec-edgar","filing":"0001209191-17-044232","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000120919117044232/doc4.xml","form_type":"4"}},{"id":4261971,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-07-06T19:10:46.000Z","date":"2017-07-03","kind":"exercise","acquired":false,"shares":11800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to the Option were fully vested as of September 1, 2015."}],"balance_after":51771,"derivative":{"exercise_price":0.52,"expiration_date":"2021-10-23","underlying":"Common Stock","underlying_shares":11800},"source":{"system":"sec-edgar","filing":"0001209191-17-044232","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000120919117044232/doc4.xml","form_type":"4"}},{"id":4261970,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-07-06T19:10:46.000Z","date":"2017-07-06","kind":"sale","acquired":false,"shares":4512,"price":11.2308,"value":50673.3696,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.10 to $11.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":39900,"source":{"system":"sec-edgar","filing":"0001209191-17-044232","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000120919117044232/doc4.xml","form_type":"4"}},{"id":4261969,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-07-06T19:10:46.000Z","date":"2017-07-06","kind":"exercise","acquired":true,"shares":4512,"price":0.52,"value":2346.24,"ownership":{"direct":true},"balance_after":44412,"source":{"system":"sec-edgar","filing":"0001209191-17-044232","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000120919117044232/doc4.xml","form_type":"4"}},{"id":4261968,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-07-06T19:10:46.000Z","date":"2017-07-05","kind":"sale","acquired":false,"shares":33688,"price":11.4562,"value":385936.4656,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.90 to $11.68, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":39900,"source":{"system":"sec-edgar","filing":"0001209191-17-044232","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000120919117044232/doc4.xml","form_type":"4"}},{"id":4261967,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-07-06T19:10:46.000Z","date":"2017-07-05","kind":"exercise","acquired":true,"shares":33688,"price":0.52,"value":17517.76,"ownership":{"direct":true},"balance_after":73588,"source":{"system":"sec-edgar","filing":"0001209191-17-044232","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000120919117044232/doc4.xml","form_type":"4"}},{"id":4261966,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-07-06T19:10:46.000Z","date":"2017-07-03","kind":"sale","acquired":false,"shares":11800,"price":11.0193,"value":130027.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.80 to $11.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":39900,"source":{"system":"sec-edgar","filing":"0001209191-17-044232","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000120919117044232/doc4.xml","form_type":"4"}},{"id":4261965,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-07-06T19:10:46.000Z","date":"2017-07-03","kind":"exercise","acquired":true,"shares":11800,"price":0.52,"value":6136.0,"ownership":{"direct":true},"balance_after":51700,"source":{"system":"sec-edgar","filing":"0001209191-17-044232","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000120919117044232/doc4.xml","form_type":"4"}},{"id":4282308,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2017-06-14T21:06:37.000Z","date":"2017-06-12","kind":"grant","acquired":true,"shares":32625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the Option vest in 48 equal monthly installments from the vesting commencement date of June 12, 2017."}],"balance_after":32625,"derivative":{"exercise_price":10.75,"expiration_date":"2027-06-11","underlying":"Common Stock","underlying_shares":32625},"source":{"system":"sec-edgar","filing":"0001209191-17-039997","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000120919117039997/doc4.xml","form_type":"4"}},{"id":4293023,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-06-05T19:25:00.000Z","date":"2017-06-05","kind":"exercise","acquired":false,"shares":17577,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to the Option were fully vested as of September 1, 2015."}],"balance_after":63571,"derivative":{"exercise_price":0.52,"expiration_date":"2021-10-23","underlying":"Common Stock","underlying_shares":17577},"source":{"system":"sec-edgar","filing":"0001209191-17-037970","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000120919117037970/doc4.xml","form_type":"4"}},{"id":4293022,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-06-05T19:25:00.000Z","date":"2017-06-02","kind":"exercise","acquired":false,"shares":48753,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to the Option were fully vested as of September 1, 2015."}],"balance_after":81148,"derivative":{"exercise_price":0.52,"expiration_date":"2021-10-23","underlying":"Common Stock","underlying_shares":48753},"source":{"system":"sec-edgar","filing":"0001209191-17-037970","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000120919117037970/doc4.xml","form_type":"4"}},{"id":4293021,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-06-05T19:25:00.000Z","date":"2017-06-01","kind":"exercise","acquired":false,"shares":77971,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to the Option were fully vested as of September 1, 2015."}],"balance_after":129901,"derivative":{"exercise_price":0.52,"expiration_date":"2021-10-23","underlying":"Common Stock","underlying_shares":77971},"source":{"system":"sec-edgar","filing":"0001209191-17-037970","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000120919117037970/doc4.xml","form_type":"4"}},{"id":4293020,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-06-05T19:25:00.000Z","date":"2017-06-05","kind":"sale","acquired":false,"shares":17577,"price":9.9919,"value":175627.6263,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.90 to $10.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":39900,"source":{"system":"sec-edgar","filing":"0001209191-17-037970","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000120919117037970/doc4.xml","form_type":"4"}},{"id":4293019,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-06-05T19:25:00.000Z","date":"2017-06-05","kind":"exercise","acquired":true,"shares":17577,"price":0.52,"value":9140.04,"ownership":{"direct":true},"balance_after":57477,"source":{"system":"sec-edgar","filing":"0001209191-17-037970","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000120919117037970/doc4.xml","form_type":"4"}},{"id":4293018,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-06-05T19:25:00.000Z","date":"2017-06-02","kind":"sale","acquired":false,"shares":48753,"price":10.0975,"value":492283.4175,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.90 to $10.33, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":39900,"source":{"system":"sec-edgar","filing":"0001209191-17-037970","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000120919117037970/doc4.xml","form_type":"4"}},{"id":4293017,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-06-05T19:25:00.000Z","date":"2017-06-02","kind":"exercise","acquired":true,"shares":48753,"price":0.52,"value":25351.56,"ownership":{"direct":true},"balance_after":88653,"source":{"system":"sec-edgar","filing":"0001209191-17-037970","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000120919117037970/doc4.xml","form_type":"4"}},{"id":4293016,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-06-05T19:25:00.000Z","date":"2017-06-01","kind":"sale","acquired":false,"shares":77971,"price":10.002,"value":779865.942,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.90 to $10.13, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":39900,"source":{"system":"sec-edgar","filing":"0001209191-17-037970","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000120919117037970/doc4.xml","form_type":"4"}},{"id":4293015,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-06-05T19:25:00.000Z","date":"2017-06-01","kind":"exercise","acquired":true,"shares":77971,"price":0.52,"value":40544.92,"ownership":{"direct":true},"balance_after":117871,"source":{"system":"sec-edgar","filing":"0001209191-17-037970","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000120919117037970/doc4.xml","form_type":"4"}},{"id":4320936,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-05-15T18:56:17.000Z","date":"2017-05-12","kind":"exercise","acquired":false,"shares":4299,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the Option were fully vested as of September 1, 2015."}],"balance_after":207872,"derivative":{"exercise_price":0.52,"expiration_date":"2021-10-23","underlying":"Common Stock","underlying_shares":4299},"source":{"system":"sec-edgar","filing":"0001209191-17-032488","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000120919117032488/doc4.xml","form_type":"4"}},{"id":4320935,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-05-15T18:56:17.000Z","date":"2017-05-11","kind":"exercise","acquired":false,"shares":1400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the Option were fully vested as of September 1, 2015."}],"balance_after":212171,"derivative":{"exercise_price":0.52,"expiration_date":"2021-10-23","underlying":"Common Stock","underlying_shares":1400},"source":{"system":"sec-edgar","filing":"0001209191-17-032488","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000120919117032488/doc4.xml","form_type":"4"}},{"id":4320934,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-05-15T18:56:17.000Z","date":"2017-05-12","kind":"sale","acquired":false,"shares":4299,"price":9.9227,"value":42657.6873,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 10, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.90 to $9.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":39900,"source":{"system":"sec-edgar","filing":"0001209191-17-032488","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000120919117032488/doc4.xml","form_type":"4"}},{"id":4320933,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-05-15T18:56:17.000Z","date":"2017-05-12","kind":"exercise","acquired":true,"shares":4299,"price":0.52,"value":2235.48,"ownership":{"direct":true},"balance_after":44199,"source":{"system":"sec-edgar","filing":"0001209191-17-032488","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000120919117032488/doc4.xml","form_type":"4"}},{"id":4320932,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-05-15T18:56:17.000Z","date":"2017-05-11","kind":"sale","acquired":false,"shares":1400,"price":9.9071,"value":13869.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 10, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.90 to $9.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":39900,"source":{"system":"sec-edgar","filing":"0001209191-17-032488","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000120919117032488/doc4.xml","form_type":"4"}},{"id":4320931,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-05-15T18:56:17.000Z","date":"2017-05-11","kind":"exercise","acquired":true,"shares":1400,"price":0.52,"value":728.0,"ownership":{"direct":true},"balance_after":41300,"source":{"system":"sec-edgar","filing":"0001209191-17-032488","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000120919117032488/doc4.xml","form_type":"4"}},{"id":4390839,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-03-10T20:04:03.000Z","date":"2017-03-09","kind":"exercise","acquired":false,"shares":6931,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to the Option vest in 48 equal monthly installments from the vesting commencement date of January 10, 2015."}],"balance_after":173289,"derivative":{"exercise_price":1.45,"expiration_date":"2025-01-09","underlying":"Common Stock","underlying_shares":6931},"source":{"system":"sec-edgar","filing":"0001209191-17-019990","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000120919117019990/doc4.xml","form_type":"4"}},{"id":4390838,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-03-10T20:04:03.000Z","date":"2017-03-09","kind":"exercise","acquired":false,"shares":3165,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the Option were fully vested as of September 1, 2015."}],"balance_after":213571,"derivative":{"exercise_price":0.52,"expiration_date":"2021-10-23","underlying":"Common Stock","underlying_shares":3165},"source":{"system":"sec-edgar","filing":"0001209191-17-019990","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000120919117019990/doc4.xml","form_type":"4"}},{"id":4390837,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-03-10T20:04:03.000Z","date":"2017-03-09","kind":"exercise","acquired":false,"shares":14904,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the Option were fully vested as of December 31, 2015."}],"balance_after":32491,"derivative":{"exercise_price":0.52,"expiration_date":"2021-10-23","underlying":"Common Stock","underlying_shares":14904},"source":{"system":"sec-edgar","filing":"0001209191-17-019990","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000120919117019990/doc4.xml","form_type":"4"}},{"id":4390836,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-03-10T20:04:03.000Z","date":"2017-03-09","kind":"sale","acquired":false,"shares":25000,"price":10.9631,"value":274077.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 2, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.75 to $11.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":39900,"source":{"system":"sec-edgar","filing":"0001209191-17-019990","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000120919117019990/doc4.xml","form_type":"4"}},{"id":4390835,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-03-10T20:04:03.000Z","date":"2017-03-09","kind":"exercise","acquired":true,"shares":6931,"price":1.45,"value":10049.95,"ownership":{"direct":true},"balance_after":64900,"source":{"system":"sec-edgar","filing":"0001209191-17-019990","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000120919117019990/doc4.xml","form_type":"4"}},{"id":4390834,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-03-10T20:04:03.000Z","date":"2017-03-09","kind":"exercise","acquired":true,"shares":3165,"price":0.52,"value":1645.8,"ownership":{"direct":true},"balance_after":57969,"source":{"system":"sec-edgar","filing":"0001209191-17-019990","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000120919117019990/doc4.xml","form_type":"4"}},{"id":4390833,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-03-10T20:04:03.000Z","date":"2017-03-09","kind":"exercise","acquired":true,"shares":14904,"price":0.52,"value":7750.08,"ownership":{"direct":true},"balance_after":54804,"source":{"system":"sec-edgar","filing":"0001209191-17-019990","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000120919117019990/doc4.xml","form_type":"4"}},{"id":4498696,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-01-05T17:15:49.000Z","date":"2017-01-03","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the Option were fully vested as of December 31, 2015."}],"balance_after":39422,"derivative":{"exercise_price":0.52,"expiration_date":"2021-10-23","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-17-002230","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000120919117002230/doc4.xml","form_type":"4"}},{"id":4498695,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-01-05T17:15:49.000Z","date":"2017-01-03","kind":"sale","acquired":false,"shares":25000,"price":11.1596,"value":278990.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 2, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.95 to $11.55, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":39900,"source":{"system":"sec-edgar","filing":"0001209191-17-002230","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000120919117002230/doc4.xml","form_type":"4"}},{"id":4498694,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-01-05T17:15:49.000Z","date":"2017-01-03","kind":"exercise","acquired":true,"shares":25000,"price":0.52,"value":13000.0,"ownership":{"direct":true},"balance_after":64900,"source":{"system":"sec-edgar","filing":"0001209191-17-002230","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000120919117002230/doc4.xml","form_type":"4"}},{"id":4522198,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2016-12-14T21:05:10.000Z","date":"2016-12-12","kind":"grant","acquired":true,"shares":29800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the Option vest in 48 equal monthly installments from the vesting commencement date of December 12, 2016."}],"balance_after":29800,"derivative":{"exercise_price":11.15,"expiration_date":"2026-12-11","underlying":"Common Stock","underlying_shares":29800},"source":{"system":"sec-edgar","filing":"0001209191-16-155281","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000120919116155281/doc4.xml","form_type":"4"}},{"id":4533450,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2016-12-05T19:21:32.000Z","date":"2016-12-01","kind":"exercise","acquired":false,"shares":2875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to the Option were fully vested as of September 1, 2015."}],"balance_after":216736,"derivative":{"exercise_price":0.52,"expiration_date":"2021-10-23","underlying":"Common Stock","underlying_shares":2875},"source":{"system":"sec-edgar","filing":"0001209191-16-153512","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000120919116153512/doc4.xml","form_type":"4"}},{"id":4533449,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2016-12-05T19:21:32.000Z","date":"2016-12-01","kind":"exercise","acquired":false,"shares":8262,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the Option were fully vested as of December 31, 2015."}],"balance_after":64422,"derivative":{"exercise_price":0.52,"expiration_date":"2021-10-23","underlying":"Common Stock","underlying_shares":8262},"source":{"system":"sec-edgar","filing":"0001209191-16-153512","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000120919116153512/doc4.xml","form_type":"4"}},{"id":4533448,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2016-12-05T19:21:32.000Z","date":"2016-12-01","kind":"exercise","acquired":false,"shares":13863,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the Option vest in 48 equal monthly installments from the vesting commencement date of January 10, 2015."}],"balance_after":180220,"derivative":{"exercise_price":1.45,"expiration_date":"2025-01-09","underlying":"Common Stock","underlying_shares":13863},"source":{"system":"sec-edgar","filing":"0001209191-16-153512","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000120919116153512/doc4.xml","form_type":"4"}},{"id":4533447,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2016-12-05T19:21:32.000Z","date":"2016-12-01","kind":"sale","acquired":false,"shares":25000,"price":10.94,"value":273500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 2, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.55 to $11.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":39900,"source":{"system":"sec-edgar","filing":"0001209191-16-153512","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000120919116153512/doc4.xml","form_type":"4"}},{"id":4533446,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2016-12-05T19:21:32.000Z","date":"2016-12-01","kind":"exercise","acquired":true,"shares":2875,"price":0.52,"value":1495.0,"ownership":{"direct":true},"balance_after":64900,"source":{"system":"sec-edgar","filing":"0001209191-16-153512","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000120919116153512/doc4.xml","form_type":"4"}},{"id":4533445,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2016-12-05T19:21:32.000Z","date":"2016-12-01","kind":"exercise","acquired":true,"shares":8262,"price":0.52,"value":4296.24,"ownership":{"direct":true},"balance_after":62025,"source":{"system":"sec-edgar","filing":"0001209191-16-153512","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000120919116153512/doc4.xml","form_type":"4"}},{"id":4533444,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2016-12-05T19:21:32.000Z","date":"2016-12-01","kind":"exercise","acquired":true,"shares":13863,"price":1.45,"value":20101.35,"ownership":{"direct":true},"balance_after":53763,"source":{"system":"sec-edgar","filing":"0001209191-16-153512","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000120919116153512/doc4.xml","form_type":"4"}},{"id":4558005,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2016-11-14T19:00:14.000Z","date":"2016-11-10","kind":"exercise","acquired":false,"shares":3938,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the Option were fully vested as of December 31, 2015."}],"balance_after":72684,"derivative":{"exercise_price":0.52,"expiration_date":"2021-10-23","underlying":"Common Stock","underlying_shares":3938},"source":{"system":"sec-edgar","filing":"0001209191-16-149950","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000120919116149950/doc4.xml","form_type":"4"}},{"id":4558004,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2016-11-14T19:00:14.000Z","date":"2016-11-10","kind":"exercise","acquired":false,"shares":21062,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the Option vest in 48 equal monthly installments from the vesting commencement date of January 10, 2015."}],"balance_after":194083,"derivative":{"exercise_price":1.45,"expiration_date":"2025-01-09","underlying":"Common Stock","underlying_shares":21062},"source":{"system":"sec-edgar","filing":"0001209191-16-149950","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000120919116149950/doc4.xml","form_type":"4"}},{"id":4558003,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2016-11-14T19:00:14.000Z","date":"2016-11-10","kind":"sale","acquired":false,"shares":25000,"price":14.7763,"value":369407.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 2, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.20 to $15.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":39900,"source":{"system":"sec-edgar","filing":"0001209191-16-149950","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000120919116149950/doc4.xml","form_type":"4"}},{"id":4558002,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2016-11-14T19:00:14.000Z","date":"2016-11-10","kind":"exercise","acquired":true,"shares":3938,"price":0.52,"value":2047.76,"ownership":{"direct":true},"balance_after":64900,"source":{"system":"sec-edgar","filing":"0001209191-16-149950","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000120919116149950/doc4.xml","form_type":"4"}},{"id":4558001,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2016-11-14T19:00:14.000Z","date":"2016-11-10","kind":"exercise","acquired":true,"shares":21062,"price":1.45,"value":30539.9,"ownership":{"direct":true},"balance_after":60962,"source":{"system":"sec-edgar","filing":"0001209191-16-149950","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000120919116149950/doc4.xml","form_type":"4"}},{"id":4584442,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2016-10-05T17:18:07.000Z","date":"2016-10-03","kind":"exercise","acquired":false,"shares":9476,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the Option were fully vested as of December 31, 2015."}],"balance_after":76622,"derivative":{"exercise_price":0.52,"expiration_date":"2021-10-23","underlying":"Common Stock","underlying_shares":9476},"source":{"system":"sec-edgar","filing":"0001209191-16-145071","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000120919116145071/doc4.xml","form_type":"4"}},{"id":4584441,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2016-10-05T17:18:07.000Z","date":"2016-10-03","kind":"exercise","acquired":false,"shares":15524,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the Option vest in 48 equal monthly installments from the vesting commencement date of January 10, 2015."}],"balance_after":215145,"derivative":{"exercise_price":1.45,"expiration_date":"2025-01-09","underlying":"Common Stock","underlying_shares":15524},"source":{"system":"sec-edgar","filing":"0001209191-16-145071","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000120919116145071/doc4.xml","form_type":"4"}},{"id":4584440,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2016-10-05T17:18:07.000Z","date":"2016-10-03","kind":"sale","acquired":false,"shares":25000,"price":12.6763,"value":316907.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 2, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.41 to $12.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":39900,"source":{"system":"sec-edgar","filing":"0001209191-16-145071","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000120919116145071/doc4.xml","form_type":"4"}},{"id":4584439,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2016-10-05T17:18:07.000Z","date":"2016-10-03","kind":"exercise","acquired":true,"shares":9476,"price":0.52,"value":4927.52,"ownership":{"direct":true},"balance_after":64900,"source":{"system":"sec-edgar","filing":"0001209191-16-145071","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000120919116145071/doc4.xml","form_type":"4"}},{"id":4584438,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2016-10-05T17:18:07.000Z","date":"2016-10-03","kind":"exercise","acquired":true,"shares":15524,"price":1.45,"value":22509.8,"ownership":{"direct":true},"balance_after":55424,"source":{"system":"sec-edgar","filing":"0001209191-16-145071","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000120919116145071/doc4.xml","form_type":"4"}},{"id":4603343,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":120921,"kind":"person","name":"Dubensky Thomas W.","position":1,"cik":"0001635590","reported_name":"Dubensky Thomas W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2016-09-14T16:13:36.000Z","date":"2016-09-12","kind":"grant","acquired":true,"shares":39900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of restricted stock units payable in common stock that vest in four equal annual installments from the grant date of September 12, 2016."}],"balance_after":39900,"source":{"system":"sec-edgar","filing":"0001209191-16-141390","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635590/000120919116141390/doc4.xml","form_type":"4"}}]}